Article
Investigation of ACE2 N-terminal fragments binding to SARS-CoV-2 Spike RBD
2020-03-20
Abstract excerpt
Coronavirus disease 19 (COVID-19) is an emerging global health crisis. With over 7 million confirmed cases to date, this pandemic continues to expand, spurring research to discover vaccines and therapies. SARS-CoV-2 is the novel coronavirus responsible for this disease. It initiates entry into human cells by binding to angiotensin-converting enzyme 2 (ACE2) via the receptor binding domain (RBD) of its spike protei...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1bd1cc75-f701-5948-b828-8c071f1c2035
- DOI
- 10.1101/2020.03.19.999318
